These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32256682)

  • 1. Application of Optimal Control to Influenza Pneumonia Coinfection with Antiviral Resistance.
    Kanyiri CW; Luboobi L; Kimathi M
    Comput Math Methods Med; 2020; 2020():5984095. PubMed ID: 32256682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A note on the use of optimal control on a discrete time model of influenza dynamics.
    González-Parra PA; Lee S; Velázquez L; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):183-97. PubMed ID: 21361407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Effects of Helminth Infection on the Transmission Dynamics of Mycobacterium tuberculosis under Optimal Control Strategies.
    Lambura AG; Mwanga GG; Luboobi L; Kuznetsov D
    Comput Math Methods Med; 2020; 2020():8869377. PubMed ID: 33281922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal control and sensitivity analysis of an influenza model with treatment and vaccination.
    Tchuenche JM; Khamis SA; Agusto FB; Mpeshe SC
    Acta Biotheor; 2011 Mar; 59(1):1-28. PubMed ID: 20140696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial coinfection in influenza: a grand rounds review.
    Chertow DS; Memoli MJ
    JAMA; 2013 Jan; 309(3):275-82. PubMed ID: 23321766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Allocation of Vaccine and Antiviral Drugs for Influenza Containment over Delayed Multiscale Epidemic Model considering Time-Dependent Transmission Rate.
    Abbasi Z; Zamani I; Amiri Mehra AH; Ibeas A; Shafieirad M
    Comput Math Methods Med; 2021; 2021():4348910. PubMed ID: 34707682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial pneumonia as an influenza complication.
    Martin-Loeches I; van Someren Gréve F; Schultz MJ
    Curr Opin Infect Dis; 2017 Apr; 30(2):201-207. PubMed ID: 27984245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.
    Boianelli A; Sharma-Chawla N; Bruder D; Hernandez-Vargas EA
    Front Cell Infect Microbiol; 2016; 6():60. PubMed ID: 27379214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal Control Analysis of Pneumonia and Meningitis Coinfection.
    Tilahun GT
    Comput Math Methods Med; 2019; 2019():2658971. PubMed ID: 31662785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of postcoinfection with influenza A virus and
    Cheng YH; You SH; Lin YJ; Chen SC; Chen WY; Chou WC; Hsieh NH; Liao CM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1973-1988. PubMed ID: 28740377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae.
    Mina MJ; Burke RM; Klugman KP
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1585-9. PubMed ID: 24789653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Influenza Virus Infection: A Roadmap for Influenza Research.
    Boianelli A; Nguyen VK; Ebensen T; Schulze K; Wilk E; Sharma N; Stegemann-Koniszewski S; Bruder D; Toapanta FR; Guzmán CA; Meyer-Hermann M; Hernandez-Vargas EA
    Viruses; 2015 Oct; 7(10):5274-304. PubMed ID: 26473911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical Analysis of Influenza A Dynamics in the Emergence of Drug Resistance.
    Kanyiri CW; Mark K; Luboobi L
    Comput Math Methods Med; 2018; 2018():2434560. PubMed ID: 30245737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling Optimal Control of In-Host HIV Dynamics Using Different Control Strategies.
    Ngina P; Mbogo RW; Luboobi LS
    Comput Math Methods Med; 2018; 2018():9385080. PubMed ID: 29971134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antiviral therapy for influenza: predictions from modeling of human infections.
    Perelson AS; Rong L; Hayden FG
    J Infect Dis; 2012 Jun; 205(11):1642-5. PubMed ID: 22448006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection With Influenza A Virus and
    Lee KM; Morris-Love J; Cabral DJ; Belenky P; Opal SM; Jamieson AM
    Front Immunol; 2018; 9():2377. PubMed ID: 30420852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.